top of page

About Us

We are on a mission to improve the outcomes for patients with neurodegenerative diseases and their families.

Meet The Team

Our leadership team has diverse professional experience across the biopharma ecosystem including an established track record in brain function discovery and multiple neurological drug regulatory approvals. This team is building on the successful preclinical and clinical research conducted at Georgetown University by members of our scientific team.  

Chris Hoyt


Charbel Moussa, MBBS, PhD

Co-Founder & Director SAB

Alison Finger


Garrett Vygantas, MD


Dan Feehan


bottom of page